Recent evidence suggests that some human cancers may harbor low-biomass microbial
ecosystems, spanning bacteria, viruses, and fungi. Bacteria, the most-studied kingdom in …

Immunotherapy has been emerging as a powerful strategy for cancer management.
Recently, accumulating evidence has demonstrated that bacteria-based immunotherapy …

Background: The microbiota is a critical component of the complex human
microenvironment, impacting various physiological processes and disease development via …

Fusobacterium nucleatum (Fn) existing in the community of colorectal cancer (CRC)
promotes CRC progression and causes chemotherapy resistance. Despite great efforts that …

Resistance to therapeutic agents is one of the major challenges in cancer therapy.
Generally, the focus is given to the genetic driver, especially the genetic mutation behind the …

Gut microbiota regulates various aspects of human physiology by producing metabolites,
metabolizing enzymes, and toxins. Many studies have linked microbiota with human health …

The infiltrating microbiota represents a novel cellular component of the solid tumour
microenvironment that can influence tumour progression and response to therapy …

The interaction between the microbial communities in the human body and the onset and
progression of cancer has not been investigated until recently. The vast majority of the …

Lung cancer mortality is exacerbated by late-stage diagnosis. Emerging evidence indicates
the potential clinical significance of distinct microbial signatures as diagnostic and …

Thyroid cancer (TC), the most frequent malignancy of the endocrine system, has recorded
an increasing incidence in the last decades. The etiology of TC remains at least partly …